IRIS UniCatt

Cenci, Tonia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.511
EU - Europa 3.166
AS - Asia 2.564
SA - Sud America 481
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
Totale 9.814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.430
DE - Germania 1.328
SG - Singapore 1.007
CN - Cina 992
SE - Svezia 513
BR - Brasile 410
IT - Italia 305
UA - Ucraina 215
GB - Regno Unito 156
FR - Francia 155
IE - Irlanda 130
VN - Vietnam 108
PL - Polonia 106
IN - India 101
ID - Indonesia 78
FI - Finlandia 71
RU - Federazione Russa 61
TR - Turchia 57
MX - Messico 38
BD - Bangladesh 35
HK - Hong Kong 29
ZA - Sudafrica 27
AR - Argentina 26
IQ - Iraq 26
JP - Giappone 26
CA - Canada 25
ES - Italia 23
NL - Olanda 21
BE - Belgio 20
LT - Lituania 15
AT - Austria 14
EC - Ecuador 14
IR - Iran 14
CI - Costa d'Avorio 12
KR - Corea 11
MA - Marocco 11
PK - Pakistan 9
SA - Arabia Saudita 9
VE - Venezuela 9
CH - Svizzera 7
TN - Tunisia 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
KE - Kenya 6
NP - Nepal 6
JM - Giamaica 5
PE - Perù 5
PY - Paraguay 5
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
KW - Kuwait 4
LV - Lettonia 4
MD - Moldavia 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
EG - Egitto 3
GE - Georgia 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
AM - Armenia 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
SN - Senegal 2
TW - Taiwan 2
UY - Uruguay 2
VG - Isole Vergini Britanniche 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CM - Camerun 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MM - Myanmar 1
MZ - Mozambico 1
PS - Palestinian Territory 1
Totale 9.808
Salva come PNG Salva come JPEG
Città #
Ashburn 734
Chandler 494
Singapore 488
Hangzhou 313
Beijing 179
Jacksonville 132
Dublin 130
Los Angeles 108
San Mateo 106
Nanjing 100
New York 93
Nürnberg 92
Warsaw 87
Wilmington 84
Ann Arbor 83
Jakarta 75
Woodbridge 71
Houston 66
Dearborn 61
Fairfield 57
Seattle 57
Cattolica 49
Munich 49
Izmir 47
Ho Chi Minh City 42
Nanchang 42
Boston 41
Milan 41
Chicago 38
Rome 38
Moscow 36
Hefei 35
Lawrence 35
Princeton 33
São Paulo 32
Frankfurt am Main 30
Bremen 29
Redwood City 29
Hyderabad 28
Hong Kong 26
Kunming 26
The Dalles 26
Helsinki 25
Redmond 25
Marseille 24
Stockholm 22
Hanoi 21
Shenyang 19
Lancaster 18
Mountain View 18
Brussels 17
Orem 17
Cambridge 15
Dallas 15
Hebei 15
Johannesburg 15
Shanghai 15
Tokyo 15
Guangzhou 14
London 14
Norwalk 14
Santa Clara 14
Buffalo 13
Denver 13
Jiaxing 13
Tianjin 13
Abidjan 12
Phoenix 12
Boardman 11
Changsha 11
Kraków 11
Leawood 11
Paris 11
Poplar 11
Porto Alegre 11
Seoul 11
Kent 10
Nuremberg 10
Rio de Janeiro 10
Zhengzhou 10
Augusta 9
Baghdad 9
Brooklyn 9
Dhaka 9
Düsseldorf 9
Fremont 9
University Park 9
Vienna 9
North Bergen 8
San Francisco 8
Auburn Hills 7
Belo Horizonte 7
Detroit 7
Jinan 7
Manchester 7
Naples 7
Pune 7
Tashkent 7
Atlanta 6
Baku 6
Totale 5.074
Salva come PNG Salva come JPEG
Nome #
Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection 591
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 480
Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas 389
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 293
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 285
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 238
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 216
Von hippel-lindau disease and erythrocytosis 192
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 181
Analysis of immunocytochemical and molecular BRAF expression in thyroid carcinomas: A cytohistologic institutional experience 171
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 167
PDGFRA-mutant syndrome 165
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 164
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 163
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 157
Diagnostic and prognostic value of immunocytochemistry and braf mutation analysis on liquid based biopsies of thyroid neoplasms suspicious for carcinoma. 153
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 142
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 139
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis. 138
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 133
The bladder epicheck test and cytology in the follow-up of patients with non-muscle-invasive high grade bladder carcinoma 133
Circulating hematopoietic stem cells and putative intestinal stem cells in coeliac disease 132
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 129
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 126
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 123
Expression of EGFRvIII in glioblastoma: prognostic significance revisited. 118
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 118
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis 117
The evaluation of miRNAs on thyroid FNAC: the promising role of miR-375 in follicular neoplasms 116
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma 115
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 115
The mutant JAK2 allele burden in children with essential thrombocythemia 114
Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights 114
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 113
Thrombopoietin receptor activation, thrombopoietin mimetic drugs, and hereditary thrombocytosis: remarks on bone marrow fibrosis 112
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 112
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma 109
Methylation study of the Paris system for reporting urinary (TPS) categories 105
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms 103
Protein Expression of PTTG-1, OCT-4, and KLF-4 in Seminoma: A Pilot Study. 103
Plexiform architecture in gastrointestinal stromal tumors is not restricted to succinate dehydrogenase-deficient cases 103
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 102
Divergent gastrointestinal stromal tumors in syndromic settings 100
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 99
Chemotherapy of Skull Base Chordoma Tailored on Responsiveness of Patient-Derived Tumor Cells to Rapamycin1,2 97
DNA methylation analysis in urinary samples: A useful method to predict the risk of neoplastic recurrence in patients with urothelial carcinoma of the bladder in the high-risk group 96
how limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid based cytology. Role of TERT promoter and BRAF V600E mutation analysis 96
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma 95
PTTG1/ZEB1 Axis Regulates E-Cadherin Expression in Human Seminoma 94
Epigenetic Silencing of Id4 Identifies a Glioblastoma Subgroup With a Better Prognosis as a Consequence of an Inhibition of Angiogenesis 93
SPTBN1 Mediates the Cytoplasmic Constraint of PTTG1, Impairing Its Oncogenic Activity in Human Seminoma 92
Telomerase inhibition in malignant gliomas. A systematic review 92
Tailored therapy for recurrent glioblastoma. Report of a personalized molecular approach 91
Dissecting Stemness in Aggressive Intracranial Meningiomas: Prognostic Role of SOX2 Expression 90
The combination cytology/epichek test in non muscle invasive bladder carcinoma follow-up: Effective tool or useless expence? 90
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia 89
Epigenetic silencing of Id4 identifies a glioblastoma subgroup with a better prognosis as a consequence of an inhibition of angiogenesis 89
Eight-year survival of a recurrent glioblastoma patient treated with molecularly tailored therapy: a case report 89
Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme 88
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 88
SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System 86
To obtain more with less cytologic samples with ancillary molecular techniques-the useful role of liquid-based cytology 82
Morphology combined with ancillary techniques: An algorithm approach for thyroid nodules 82
Upper urothelial tract high-grade carcinoma: comparison of urine cytology and DNA methylation analysis in urinary samples. 80
Pituitary-tumour-transforming-gene 1 expression in testicular cancer 79
Expression of the stem cell marker CD133 in recurrent glioblastoma and its value for prognosis 76
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 76
Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas 75
Erratum: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells (Nature (2010) 468 (824-828)) 75
The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature 75
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies with Aggressive Behavior 70
Paths of Evolution of Progressive Anaplastic Meningiomas: A Clinical and Molecular Pathology Study 70
Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin 61
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 61
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response 59
The Immunohistochemical Analysis of SOCS3 Protein Identifies a Subgroup of Prostatic Cancer Biopsies With Aggressive Behavior 44
Totale 9.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.467
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021295 0 0 0 0 0 42 51 6 69 25 88 14
2021/2022661 70 42 16 64 57 20 16 96 28 45 87 120
2022/20231.344 196 198 101 208 93 159 54 85 155 28 47 20
2023/20241.116 27 203 25 50 16 92 265 261 6 30 65 76
2024/20251.277 32 29 119 40 106 51 44 55 179 145 255 222
2025/20262.035 490 121 193 432 660 139 0 0 0 0 0 0
Totale 9.908